{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:58:40Z","timestamp":1788037120816,"version":"build-2784847793"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clp.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T23:27:51Z","timestamp":1732318071000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transplacental Antibodies"],"prefix":"10.1016","volume":"52","author":[{"given":"Alexandra K.","family":"Medoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Puopolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2024.10.007_bib1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(21)01207-1","article-title":"Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2024.10.007_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fimmu.2020.00588","article-title":"Mechanisms of fetal t\u00a0cell tolerance and immune regulation","volume":"11","author":"Rackaityte","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fimmu.2020.00555","article-title":"Vertically transferred immunity in neonates: mothers, mechanisms and mediators","volume":"11","author":"Albrecht","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.chom.2022.04.007","article-title":"Maternal immune protection against infectious diseases","volume":"30","author":"Langel","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clp.2024.10.007_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.clp.2024.10.007_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cell.2019.05.044","article-title":"Fc glycan-mediated regulation of placental antibody transfer","volume":"178","author":"Jennewein","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.clp.2024.10.007_bib7","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.clp.2024.10.007_bib8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of igg subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","article-title":"The impact of IgG transplacental transfer on early life immunity","volume":"2","author":"Fouda","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.clp.2024.10.007_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3389\/fimmu.2020.00810","article-title":"Relevance of the materno-fetal interface for the induction of antigen-specific immune tolerance","volume":"11","author":"Mimoun","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature","volume":"87","author":"van den Berg","year":"2011","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.clp.2024.10.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011109","article-title":"Quantitative mechanistic model reveals key determinants of placental IgG transfer and informs prenatal immunization strategies","volume":"19","author":"Wessel","year":"2023","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.clp.2024.10.007_bib14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/infdis\/jiac222","article-title":"HIV-associated alterations of the biophysical features of maternal antibodies correlate with their reduced transfer across the placenta","volume":"226","author":"Taylor","year":"2022","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib15","first-page":"415","article-title":"Reduced transplacental transfer of group b streptococcus surface protein antibodies in hiv-infected mother-newborn dyads","volume":"215","author":"Dzanibe","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcv.2017.07.009","article-title":"Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease","volume":"94","author":"Jallow","year":"2017","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.clp.2024.10.007_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.614246","article-title":"Reduced placental transfer of antibodies against a wide range of microbial and vaccine antigens in HIV-infected women in Mozambique","volume":"12","author":"Alonso","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s40475-020-00213-2","article-title":"Placental malaria","volume":"7","author":"Zakama","year":"2020","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/322808","article-title":"The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population","volume":"184","author":"Okoko","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(94)90991-1","article-title":"Reduced transfer of tetanus antibodies with placental malaria","volume":"343","author":"Brair","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2024.10.007_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00039-17","article-title":"Parasitic infections in pregnancy decrease placental transfer of antipneumococcus antibodies","volume":"24","author":"McKittrick","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/jiv401","article-title":"Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea","volume":"213","author":"Atwell","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib23","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/AOG.0000000000002301","article-title":"Committee Opinion No. 718: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2024.10.007_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2021.08.054","article-title":"An update on COVID-19 and pregnancy","volume":"226","author":"Jamieson","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2024.10.007_bib25","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/AOG.0000000000005479","article-title":"Influenza in pregnancy: prevention and treatment: ACOG Committee Statement No. 7","volume":"143","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.clp.2024.10.007_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2024.10.007_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the advisory committee on immunization practices - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.15585\/mmwr.mm6917a2","article-title":"Progress toward maternal and neonatal tetanus elimination - worldwide, 2000-2018","volume":"69","author":"Njuguna","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine","volume":"177","author":"Skoff","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2024.10.007_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciw633","article-title":"Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants","volume":"64","author":"Winter","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.15585\/mmwr.mm7111a2","article-title":"Progress toward achieving and sustaining maternal and neonatal tetanus elimination - worldwide, 2000-2020","volume":"71","author":"Kanu","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2024.10.007_bib33","doi-asserted-by":"crossref","first-page":"i102","DOI":"10.1093\/ije\/dyq027","article-title":"Tetanus toxoid immunization to reduce mortality from neonatal tetanus","volume":"39","author":"Blencowe","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clp.2024.10.007_bib34","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1016\/j.vaccine.2020.05.036","article-title":"Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status","volume":"38","author":"Post","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.clp.2024.10.007_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.15585\/mmwr.mm7314a1","article-title":"Measles - United States, January 1, 2020-March 28, 2024","volume":"73","author":"Mathis","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal measles antibodies in era of measles elimination: longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2024.10.007_bib38","first-page":"1","article-title":"Prevention. prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the advisory committee on immunization practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.clp.2024.10.007_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2023.0166","article-title":"Measles serostatus among parturient patients at 2 Philadelphia Hospitals in 2021","volume":"329","author":"Flannery","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2024.10.007_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajem.2022.03.060","article-title":"The association between pregnancy and COVID-19: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clp.2024.10.007_bib41","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/ciab432","volume":"73","author":"Galang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s15010-022-01777-z","article-title":"Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy","volume":"50","author":"Manciulli","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.clp.2024.10.007_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s15010-022-01829-4","article-title":"Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy","volume":"51","author":"Folkman","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.clp.2024.10.007_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.40993","article-title":"Comparison of maternal and neonatal antibody levels after COVID-19 vaccination vs SARS-CoV-2 Infection","volume":"5","author":"Flannery","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clp.2024.10.007_bib45","article-title":"Neutralizing antibodies in milk and blood of lactating women vaccinated for SARS-CoV-2: a systematic review","volume":"43","author":"Vieira","year":"2024","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.clp.2024.10.007_bib46","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064252","article-title":"Maternal COVID-19 vaccination and prevention of symptomatic infection in infants","volume":"153","author":"Cardemil","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2024.10.007_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for covid-19 among infants","volume":"387","author":"Halasa","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2024.10.007_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41390-022-02421-0","article-title":"Systematic review and meta-analysis of neonatal outcomes of COVID-19 vaccination in pregnancy","volume":"94","author":"Zhang","year":"2023","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clp.2024.10.007_bib50","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1056\/NEJMoa051721","article-title":"Influenza-associated deaths among children in the United States, 2003-2004","volume":"353","author":"Bhat","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.clp.2024.10.007_bib51","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/cid\/ciac296","article-title":"Epidemiology, clinical characteristics, and outcomes of influenza-associated hospitalizations in US children over 9 seasons following the 2009 H1N1 Pandemic","volume":"75","author":"Kamidani","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib52","article-title":"Influenza-associated pediatric deaths in the United States, 2010-2016","volume":"14","author":"Shang","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2024.10.007_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/M21-3668","article-title":"Characteristics and outcomes of hospitalized pregnant women with influenza, 2010 to 2019 : a repeated cross-sectional study","volume":"175","author":"Holstein","year":"2022","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.clp.2024.10.007_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2016.12.012","article-title":"Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies","volume":"35","author":"Mertz","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clp.2024.10.007_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2012.06.068","article-title":"Effects of influenza on pregnant women and infants","volume":"207","author":"Rasmussen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2024.10.007_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/joim.12947","article-title":"Effectiveness of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants","volume":"286","author":"Molgaard-Nielsen","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.clp.2024.10.007_bib57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.vaccine.2021.11.084","article-title":"Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood","volume":"40","author":"Foo","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.clp.2024.10.007_bib58","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/jix629","article-title":"Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study","volume":"217","author":"Ohfuji","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2024.10.007_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.acap.2011.08.006","article-title":"Assessment of parental report for 2009-2010 seasonal and monovalent H1N1 influenza vaccines among children in the emergency department or hospital","volume":"12","author":"Poehling","year":"2012","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.clp.2024.10.007_bib60","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/INF.0000000000001258","article-title":"Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study","volume":"35","author":"Regan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2024.10.007_bib61","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.vaccine.2020.12.049","article-title":"Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies","volume":"40","author":"Albrecht","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.clp.2024.10.007_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.13234","article-title":"The impact of timing of maternal influenza immunization on infant antibody levels at birth","volume":"195","author":"Zhong","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clp.2024.10.007_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ijgo.14686","article-title":"Maternal influenza vaccination preferentially boosts hemagglutinin stem-specific antibody resulting in efficient transplacental transfer of stem-specific IgG","volume":"162","author":"Zuber","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clp.2024.10.007_bib64","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2024.10.007_bib66","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","article-title":"Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2024.10.007_bib67","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","author":"Committee on Infectious","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2024.10.007_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2024.10.007_bib69","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices - United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2024.10.007_bib71","unstructured":"Available at: https:\/\/www.cdc.gov\/rsv\/vaccines\/protect-infants.html (Accessed 27 September 2024)."},{"issue":"9","key":"10.1016\/j.clp.2024.10.007_bib72","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clp.2024.10.007_bib73","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20736","article-title":"Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis","volume":"4","author":"Ssentongo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clp.2024.10.007_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2005.09.016","article-title":"Congenital cytomegalovirus (CMV) infection and hearing deficit","volume":"35","author":"Fowler","year":"2006","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.clp.2024.10.007_bib75","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3476(97)70248-8","article-title":"Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection","volume":"130","author":"Fowler","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2024.10.007_bib76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mpd.2001.112061","article-title":"Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection","volume":"138","author":"Noyola","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2024.10.007_bib77","series-title":"Textbook of clinical Pediatrics","first-page":"1145","article-title":"CMV infections","author":"Ross","year":"2012"},{"key":"10.1016\/j.clp.2024.10.007_bib78","article-title":"Development of a vaccine against human cytomegalovirus: advances, barriers, and implications for the clinical practice","volume":"9","author":"Scarpini","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.clp.2024.10.007_bib79","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.vaccine.2023.06.020","article-title":"Vaccine value profile for cytomegalovirus","volume":"41","author":"Boppana","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.clp.2024.10.007_bib80","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.clp.2024.10.007_bib81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2024.10.007_bib82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group b streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510824001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510824001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T14:13:23Z","timestamp":1749737603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510824001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0095510824001076"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2024.10.007","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplacental Antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}